Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

temozolomide

  • You have access
    Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
    Chun Wang, Qiushi Li, Jian Xiao and Yang Liu
    Cancer Biology & Medicine May 2023, 20 (5) 325-343; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0761
  • You have access
    Expert opinion on translational research for advanced glioblastoma treatment
    Xiaoteng Cui, Yunfei Wang, Junhu Zhou, Qixue Wang and Chunsheng Kang
    Cancer Biology & Medicine May 2023, 20 (5) 344-352; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0012
  • You have access
    Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA
    Kenan Zhang, Xing Liu, Guanzhang Li, Xin Chang, Shouwei Li, Jing Chen, Zheng Zhao, Jiguang Wang, Tao Jiang and Ruichao Chai
    Cancer Biology & Medicine October 2022, 19 (10) 1460-1476; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0469
  • You have access
    Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
    Ruichao Chai, Guanzhang Li, Yuqing Liu, Kenan Zhang, Zheng Zhao, Fan Wu, Yuzhou Chang, Bo Pang, Jingjun Li, Yangfang Li, Tao Jiang and Yongzhi Wang
    Cancer Biology & Medicine February 2021, 18 (1) 271-282; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0179
  • You have access
    Downregulation of SNRPG induces cell cycle arrest and sensitizes human glioblastoma cells to temozolomide by targeting Myc through a p53-dependent signaling pathway
    Yulong Lan, Jiacheng Lou, Jiliang Hu, Zhikuan Yu, Wen Lyu and Bo Zhang
    Cancer Biology & Medicine February 2020, 17 (1) 112-131; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0164
  • You have access
    Autophagic flux response and glioblastoma sensitivity to radiation
    Achilleas G. Mitrakas, Dimitra Kalamida, Alexandra Giatromanolaki, Stamatia Pouliliou, Avgi Tsolou, Rafail Kyranas and Michael I. Koukourakis
    Cancer Biology & Medicine August 2018, 15 (3) 260-276; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0173

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire